(Q42858753)

8 November 2017

Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells (English)

1 reference

8 November 2017

1 reference

Ojugo AS

1

1 reference

8 November 2017

McSheehy PM

2

1 reference

8 November 2017

Stubbs M

3

1 reference

8 November 2017

Alder G

4

1 reference

8 November 2017

Bashford CL

5

1 reference

8 November 2017

Maxwell RJ

6

1 reference

8 November 2017

Leach MO

7

1 reference

8 November 2017

Judson IR

8

1 reference

8 November 2017

Griffiths JR

9

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

British Journal of Cancer

8 November 2017

1 reference

8 November 2017

77

1 reference

8 November 2017

6

1 reference

8 November 2017

873-879

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.144

8 November 2017

0 references

cites work

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

In vivo monitoring of fluoropyrimidine metabolites: magnetic resonance spectroscopy in the evaluation of 5-fluorouracil.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

A novel method for measuring intracellular pH and potassium concentration

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Fluorinated pyrimidines and their nucleosides

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Enzymes of uracil catabolism in normal and neoplastic human tissues

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-fluorouracil, using 19F nuclear magnetic resonance spectroscopy.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

27 May 2018

Are cancer cells acidic?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Detection of differential sensitivity to 5-fluorouracil in ehrlich ascites tumour cells by19F NMR spectroscopy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Primary amines enhance the antiviral activity of interferon against a membrane virus: role of intracellular pH.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150086

Active Transport of 5-Fluorouracil and Its Energy Coupling in Ehrlich Ascites Tumor Cells1

27 May 2018

1 reference

12 December 2020

Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats

1 reference

12 December 2020

Plasma membrane potential of Lettré cells does not depend on cation gradients but on pumps

1 reference

12 December 2020

Regulation of pH in murine tumor and muscle

1 reference

12 December 2020

pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy

1 reference

12 December 2020

Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma

1 reference

12 December 2020

An assessment of31P MRS as a method of measuring pH in rat tumours

1 reference

12 December 2020

The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study

1 reference

12 December 2020

Measurement of ion fluxes and pH gradients across cell membranes

1 reference

12 December 2020

5-Fluorouracil causes alterations in the pharmacokinetic profile of tauromustine in NMRI mice

1 reference

12 December 2020

Association of intratumoral pharmacokinetics of fluorouracil with clinical response

1 reference

12 December 2020

Measurement of plasma 5-fluorouracil by high-performance liquid chromatography with comparison of results to tissue drug levels observed using in vivo 19F magnetic resonance spectroscopy in patients on a protracted venous infusion with or without int

1 reference

12 December 2020

Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.144

1 reference

8 November 2017

1 reference

8 November 2017

1 reference